-
Views
-
Cite
Cite
A.K. Kakkar, J.-P. Bassand, S.Z. Goldhaber, G. Agnelli, D. Atar, E. Berge, F. Cools, S. Haas, S.K. Rushton-Smith, W. Hacke, on behalf of GARFIELD Investigators , One-year outcomes in atrial fibrillation patients with versus without a previous stroke or transient ischaemic attack: findings from the international prospective GARFIELD registry, European Heart Journal, Volume 34, Issue suppl_1, 1 August 2013, P386, https://doi.org/10.1093/eurheartj/eht307.P386
- Share Icon Share
Purpose: We sought to compare 1-year outcomes in atrial fibrillation (AF) patients with versus without a previous stroke or transient ischaemic attack (TIA) using data from the prospective international GARFIELD Registry.
Methods: The population comprised consecutively recruited adult patients with newly diagnosed (≤6 weeks) non-valvular AF and ≥1 additional investigator-defined stroke risk factor(s). The effect of previous stroke/TIA was investigated using a Cox proportional hazards model, adjusting for age, sex, heart failure/left ventricular dysfunction, hypertension, diabetes, vascular disease and antithrombotic treatments.
Results: Of 10,608 AF patients, 14% had a history of stroke/TIA. These patients had a higher cardiovascular risk profile vs patients without a history of stroke/TIA: mean±SD CHADS2 3.7±0.9 vs 1.6±0.9; CHA2DS2-VASc 5.2±1.4 vs 2.9±1.4; HAS-BLED 1.7±0.9 vs 0.9±0.7; all p<0.001. Regarding oral antithrombotic treatments initiated at AF diagnosis, patients with a previous stroke/TIA had a higher rate of vitamin K antagonist use (63% vs 55%), a lower rate of antiplatelets alone use (22% vs 26%) and fewer received no antithrombotic treatment (9% vs 15%) (overall p<0.001 for treatments). After adjustment, previous stroke/TIA was associated with a higher risk of stroke, death, and intracranial haemorrhage, but not overall major bleeds, at 1 year (table).
Adjusted HRs for events at 1 year*
Event . | Adjusted HR (95% CI) . | P value . |
---|---|---|
Stroke/systemic embolism | 3.13 (2.13–4.61) | <0.001 |
Death (all cause) | 1.39 (1.01–1.93) | 0.047 |
Major bleed | 0.83 (0.39–1.77) | 0.63 |
Intracranial haemorrhage | 3.08 (1.09–8.65) | 0.033 |
Event . | Adjusted HR (95% CI) . | P value . |
---|---|---|
Stroke/systemic embolism | 3.13 (2.13–4.61) | <0.001 |
Death (all cause) | 1.39 (1.01–1.93) | 0.047 |
Major bleed | 0.83 (0.39–1.77) | 0.63 |
Intracranial haemorrhage | 3.08 (1.09–8.65) | 0.033 |
*For patients with vs without previous stroke/TIA. CI, confidence interval; HR, hazard ratio.
Conclusion: In everyday clinical practice, AF patients with a history of stroke/TIA are at greater risk of fatal and non-fatal events within the first year of diagnosis than those without a history of stroke/TIA.
- atrial fibrillation
- fibrinolytic agents
- hypertension
- transient ischemic attack
- intracranial hemorrhages
- diabetes mellitus
- ventricular dysfunction, left
- heart disease risk factors
- hemorrhage
- cerebrovascular accident
- vascular diseases
- ischemic stroke
- heart failure
- diabetes mellitus, type 2
- adult
- diagnosis
- embolism
- vitamin k antagonists
- stroke risk
- chads2 score
- has-bled score
- cha2ds2-vasc score